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Abstract: Croton nepetaefolius is a native plant from northeastern Brazil that belongs to 
the Euphorbiaceae family. The biological action of this plant has been extensively 
explored, being the secondary metabolites responsible for its properties alkaloids, 
diterpenes, and triterpenes. This study aimed to evaluate the ability of casbane diterpene 
(CD), isolated from the ethanolic extract of C. nepetaefolius, to inhibit microbial growth 
and biofilm formation of several clinical relevant species (bacteria and yeasts). It was 
found that CD possessed biocidal and biostatic activity against the majority of the species 
screened, with minimal active concentrations ranging between 125 and 500 µg/mL. In 
addition, it was observed that biofilm formation was inhibited even when the planktonic 
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growth was not significantly affected. In conclusion, CD showed potential to be a natural 
tool for the treatment of diseases caused by different infectious microorganisms. 
Keywords: casbane diterpene; biofilm-associated infections control; natural 
antimicrobials; bacteria and yeast 
 
1. Introduction  
In Nature, microorganisms often attach to surfaces and embed themselves in a matrix composed of 
extracellular polymeric substances, that they properly produce, forming a sessile population called 
biofilms [1,2]. Moreover, it is known that surface-associated microorganisms exhibited a distinct 
phenotype with respect to gene transcription, growth rate and enhanced resistance to antimicrobials [3,4]. 
Biofilms are sources of diverse problems in various areas. In dairy industry, biofilms are often 
sources of biological contaminants and they also contribute to increased equipment corrosion rates [5]. 
In the public health sector, the colonization of medical surfaces, such as catheters and other indwelling 
devices, by biofilms, plays a decisive role in the problem of healthcare-associated infections [6]. Thus, 
over the years, many efforts have been put on the control of microbial adhesion and biofilm  
formation [7-11]. 
Currently, natural products are recognized as important antimicrobial agents with structural and 
mode of action diversity. Therefore, natural plant compounds have been used by many research groups 
with the intent of discovering new antimicrobial and anti-biofilm drugs or alternatives to antibiotic 
therapy [12-14]. Several thousand antimicrobial products have been discovered so far, showing high 
potential for therapeutical use [15]. 
The genus Croton of the plant family Euphorbiaceae is widespread in northeastern Brazil. The use 
of this genus in opular medicine includes treatments for cancer, constipation, diabetes, digestive 
problems, dysentery, external wounds, fever, hypercholesterolemia, hypertension, inflammation, 
intestinal worms, malaria, pain, ulcers, and weight-loss [16]. Previous phytochemical investigations 
have shown that plants of this genus produce alkaloids [17,18], flavonoids [19-21], triterpenoids and 
steroids [22,23], and a large number of diterpenoids [24-28]. Croton nepetaefolius is an aromatic plant 
native of the Northeast of Brazil which is extensively used in folk medicine as a sedative and 
antispasmodic agent [29]. Terpenoids are a class of secondary metabolites made of isoprene units. 
These molecules are reported as possessing antimicrobial properties [30,31], highlighting the 
antimicrobial potential of this important class of compounds.  
In the present study, the biostatic and biocidal effects of casbane diterpene, a diterpenoid isolated 
from Croton nepetaefolius, was assessed against a wide range of microorganisms, both yeast and 
bacteria. Moreover, the effects of this compound on biofilm formation was also evaluated.  
2. Results and Discussion 
Bacteria and fungi are widely distributed in Nature, being some of them pathogenic and directly 
involved in several infectious diseases, such as cystic fibrosis, endocarditis, and periodontitis [32]. The 




casbane diterpene (CD) fraction extracted from Croton nepataefolius showed antimicrobial activity 
against some microorganisms tested (Figures 1 and 2). The presence of CD during bacteria growth 
clearly interfered with the Gram-positive bacterial planktonic and sessile development, inhibiting or 
reducing its growth. Concerning Staphylococcus aureus, 125 µg/mL of CD decreased its planktonic 
growth around 74% according to control absorbance, with MIC 250 µg/mL and MMC 500 µg/mL 
(Figure 1a). CD also interfered with the establishment of S. aureus biofilms, inhibiting their 
development at concentrations above 125 µg/mL (Figure 2a).  
Figure 1. Antimicrobial activity of CD on the planktonic growth of bacterial (a-j) and 
yeasts (k-m). * p < 0.01 and ** p < 0.001 related to control. 
 




Figure 2. Antibiofilm effect of CD on bacterial (a-j) and yeasts (k-m). *p < 0.01 and  
** p < 0.001 related to control. 
 
Regarding Staphylococcus epidermidis strains, CD also showed ability to reduce their planktonic 
growth at concentrations above 62.4 µg/mL, with MIC of 500 µg/mL without bactericidal activity 




(Figures 1b and 1c). Biofilm formation by S. epidermidis CECT 4183 is clearly disturbed by CD at 
doses above 250 µg/mL (Figure 2b). No significant effect was found on S. epidermidis CECT 231 
(Figure 2c). So, based on the results it can be concluded that CD exhibited excellent antibacterial 
profile on the Gram-positive bacteria tested. 
As already reported [33,34], the cell membrane has a great importance in many cellular processes, 
including permeability, cell growth and division. Considering the chemical characteristics of the 
molecule tested, hidrophobicity and polarity, a non-specific interaction with membrane phospholipids, 
destabilizing the non-covalent interactions between the fatty acids of the lipid bilayer, and thus 
interfering with the cellular development of the Gram-positive bacteria can be suggested. Molecules 
with lipophilic characteristics such as anthraquinones are known antimicrobial substances, which 
exhibit such an effect of interaction with cell membrane phospholipids [35,36]. The effect on biofilm 
formation by the Gram-positive staphylococcal strains seems to be directly related to the growth 
inhibition, showing non-specific action related to the antibiofilm activity. 
The effect of CD was different on Gram-negative strains, being able to interfere only in the 
development of the biofilm, without affecting the planktonic growth, with the exception of P. 
fluorescens ATCC 13525 (Figure 1d). The presence of the outer membrane in Gram-negative bacteria 
constitutes a barrier for permeability of hydrophobic molecules [37]. Thus, the interaction of CD with 
the cellular membrane was limited, and the antibacterial effect was inhibited. These microorganisms, 
when associated in biofilms, are structurally and physiologically different from planktonic bacteria, for 
example, in their resistance to antibiotics [38]. 
In recent years, researchers have explored the activity of natural products possessing the ability to 
interfere with the development of biofilms [39,40]. At the lowest concentration (15.6 µg/mL) biofilm 
formation by Klebsiella pneumoniae ATCC 11296 was decreased by about 45% (Figure 2d). 
Concerning Pseudomonas aeruginosa ATCC 10145, CD at doses ranging between 31.2 and  
125 µg/mL induced biofilm mass production, while concentrations above 250 µg/mL strongly 
inhibited biofilm development by around 80% (Figure 2f). A similar trend occurred for Pseudomonas 
aeruginosa CGCT 111 and Escherichia coli K12 strains, since the highest concentration of CD led to 
an inhibition of 86% (Figure 2g and Figure 2i). The increase of biomass observed in the P. aeruginosa 
ATCC10145 can be explained by stress induced by the presence of the tested substance that maybe 
leads to an extra production of exopolysaccharides (EPS) by the bacterial cell. A similar effect was 
observed at sub-inhibitory concentrations of cefotaxime, which significantly induced the production of 
biofilm mass as well as EPS of three Salmonella enterica isolates [41]. Against Pseudomonas 
fluorescens, CD showed MIC and MMC of 125 µg/mL and 250 µg/mL, respectively (Figure 1d). 
Moreover, there was no biofilm formation by this Gram-negative strain at concentrations above  
125 µg/mL (Figure 2h). The lipopolysaccharide (LPS) present in the cell surface, placed on outer 
leaflet of the outer membrane of all Gram-negative bacteria, forms the first point of contact between 
the bacterial cell and any surface that it colonizes or binding to therapeutic agents [42]. Studies 
indicate that biofilm formation of P. aeruginosa is directly related to the type of LPS produced by the 
cell [43]. Thus, the effect of CD on inhibition of biofilm formation may be related to an interaction 
between CD and LPS, which might affect the adherence properties influencing thus biofilm formation 
by these strains. 




As occurred in Gram-positive bacteria, CD was effective on planktonic growth of the yeasts tested. 
On C. albicans and C. tropicalis strains CD, at concentrations of 500 µg/mL, reduced viability of 
planktonic growth in 59% and 29%, respectively (Figure 1k and Figure 1l). However, on C. glabrata, 
the CD was effective in a lower concentration (15.6 µg/mL) and was able to decrease by 72% the yeast 
viability when its concentration was 500 µg/mL (Figure 1m). In the biofilm formation experiments 
using yeasts, CD proved to be effective on C. albicans and C. tropicalis strains, showing a dose-
response relationship (Figure 2k and Figure 2l). Regarding C. tropicalis, CD at a concentration of  
15.6 µg/mL decreased more than 50% the yeast ability to form biofilm (Figure 2l). When used against 
C. albicans, 62.5 µg/mL of the CD was necessary to achieve the same reduction (Figure 2k). On the 
other hand, CD increased the biomass production of C. glabrata (Figure 2m). The differences in CD 
activity can be explained by differences in phosphoglycerides components and fatty acyl chains of 
Candida species [44]. 
3. Experimental  
3.1. Plant material 
Stalks from C. nepetaefolius were collected in Caucaia – Ceará (Brazil) in May 2004. The material 
was identified by Dr. Edson Paula Nunes at the Herbário Prisco Bezerra (EAC), Departamento de 
Biologia, Universidade Federal do Ceará, Fortaleza, CE, Brazil, where the voucher specimens (No. 
33.582) were deposited.  
3.2. Extraction and isolation of casbane diterpene 
The bark (5.0 kg) of C. nepetaefolius was powdered and extracted with ethanol (EtOH), (10 L × 3, 
for three days) at room temperature. The solvent was removed under reduced pressure to give an EtOH 
extract (58.2 g) that was fractionated coarsely on a silica gel column by elution with hexane (fractions 
1-15), hexane/ethyl acetate (EtOAc) (1:1 fractions 16-25), EtOAc (fractions 26-40), and EtOH 
(fractions 41-48), affording a total of 48 fractions of 100 mL each. The hexane fractions (22.5 g) were 
pooled and fractionated on a silica gel column using hexane (fractions 1'-10'), hexane/EtOAc (1:1 F' 
11-16), EtOAc (F' 17-21) and  EtOH (F' 22-25), providing 25 fractions of 100 mL each. Fractions  
11'-16' (14.0), obtained with hexane/EtOAc (1:1), was fractionated coarsely on a silica gel column by 
elution with hexane (F'' 1), hexane/EtOAc (9:1 F'' 2-5; 8:2 F'' 6-15; 7:3 F'' 16-32), EtOAc (F'' 33), 
providing 33 fractions of 100 mL each. Fractions 10''-13'', obtained with hexane/EtOAc (8:2), yielded 
diterpene named 1,4-dihydroxy-2E,6E,12E-trien-5-one-casbane (3.0 g, 0.06%; Figure 3). 
 








3.3. Preparation of the CD stock solution  
The CD was solubilized in dimethyl sulfoxide (DMSO), and then diluted in culture medium  
(1 mg/mL), with a maximum percentage of 4% of DMSO. Controls were performed to confirm that 
this dose of DMSO did not interfere with microbial growth. 
 
3.4. Microorganisms  
In the present study, the microorganisms used in the experiments were: Gram negative bacteria 
(Pseudomonas fluorescens ATCC13525, Pseudomonas aeruginosa ATCC10145, P. aeruginosa 
CGCT111, Klebsiella oxytoca ATCC13182, Klebsiella pneumoniae ATCC11296, Escherichia coli 
K12 MG 1655, and Escherichia coli CECT434), Gram-positive bacteria (Staphylococcus epidermidis 
CECT231, S. epidermidis CECT4183, and S. aureus ATCC), and yeasts (Candida albicans 
ATCC90028, C. tropicalis ATCC750 and C. glabratta ATCC2001).  
 
3.5. Culture conditions 
For each microorganism, a culture stock was prepared on Tryptic Soy broth (TSB) plus 20% 
glycerol and preserved at -80 °C. Then, the microorganisms were transferred into Petri dishes 
containing TSA and incubated at 37 °C, for 24 h. After growth on the solid medium, an isolated colony 
was removed and inoculated into 10 mL of TSB and incubated for 18 h at 37 °C under constant 
agitation of 120 rpm. Prior to use, the cell concentration of each inoculum was adjusted to  
1 × 106 cells/mL through the use of spectrophotometer and calibration curves, previously determined 
for each bacterium. The yeasts were cultured for 24 h in RPMI 1640 buffered with MOPS at pH 7.0 in 
constant agitation of 120 rpm. Then, the concentration of each yeast inoculum was adjusted to  
1 × 106 cells/mL using a Neubauer chamber. 
 




3.6. Antimicrobial assays 
The antimicrobial effects of CD were determined by the broth microdilution method in 96-well 
polystyrene plates, according to the guideline Methods for Dilution Antimicrobial Susceptibility Tests 
for Bacteria That Grow Aerobically; Approved Standard – Sixth Edition (NCCLS document M7-A6). 
CD was diluted in culture medium, RPMI 1640 for yeast or TSB for bacteria, to achieve 15.6 to  
500 µg/mL were incubated aerobically with 1 × 106 cells/mL, initial concentration of cells, on a 
horizontal shaker (120 rpm/min), at 37 °C, during 24 h. The optical density at 640 nm (OD640) of each 
well content was recorded using an automated Elisa Reader (Synergy TM HT Multi-Detection 
Microtiter Reader), as a measure of microbial growth.  
The minimum inhibitory concentration (MIC) for each microorganism was determined as the lowest 
concentration of CD at which there is complete inhibition of visible growth of the organism. To 
determine the minimum microbicidal concentration (MMC), 10 μL of the bacteria/yeast planktonic 
cultures, where no visible microbial growth was observed, were inoculated in petri dishes with TSA 
medium and incubated at 37 °C for 24 h. MMC was considered as being the lowest concentration able 
to completely inhibit microbial growth on the plates. 
3.7. Antibiofilm activity 
The methodology used to grow biofilms was based on the microtiter plate test developed by 
Stepanovic et al. [45], with some modifications. Sterile 96-well polypropylene tissue culture plates 
(Orange Scientific, Braine-l’Alleud, Belgium) (with flat-bottom) were prepared using a procedure 
similar to the one used in the antimicrobial activity tests with same initial concentration of cells. All 
the plates were incubated aerobically on a horizontal shaker (120 rpm/min), at 37 °C during 24 h for 
biofilm development. After biofilm growth in the presence or absence of same CD concentrations, the 
content of each well was removed and the biofilms were washed twice with  
200 µL/well of sterilized water, to remove cells weakly adhered, being reserved for posterior analysis.  
Biomass quantification: The attached biofilm mass was quantified using crystal violet staining [46]. 
Briefly, the plates containing the biofilms were let to air dry for 30 min, and 200 µL of absolute 
methilic alcohol were transferred to each well, in order to fix the adhered cells, and allowed to contact 
during for 15 min. After 15 min, the methanol was removed and 200 µL of crystal violet 1% (Gram 
colour-staining set for microscopy; Merck) per well were added for 5 min. After the staining step, the 
washing process, with sterile water, was repeated and the plates were placed at room temperature for 1 
hour. To re-solubilize the dye bounded to biofilms, 200 µL of 33% (v/v) glacial acetic acid (Merck) 
was added to each well and place in agitation for 15 min. The CV solutions obtained were transferred 
to a new sterile 96-well plate and the optical density of the content of each well was measured using a 
microtiter plate spectrophotometer (Sunrise - Tecam) at 570 nm. 
3.8. Statistical analysis 
Statistical analyses were performed by GraphPad Prism® version 3.00 from Microsoft Windows®. 
The method used was one-way ANOVA with Bonferroni post hoc test. The data were obtained in 




triplicates from at least three separate experiments. The graphs were presented as mean ± standard 
deviation. The data were considered significant when p < 0.01 or p < 0.001. 
4. Conclusions 
Biofilm eradication is a crucial step for the treatment of various diseases. In the present work, a 
novel and natural agent with a promising antimicrobial activity was described. Casbane diterpene (CD) 
showed antimicrobial effect on planktonic forms and biofilm from some bacteria and yeasts. The 
results showed that CD can be considered as a promising molecule with potential for the 
pharmacological treatment of biofilm-associated infections. Additional toxicological studies need to be 
performed to validate its applicability. 
 
Acknowledgements 
This study was supported by FUNCAP and CNPq (Brazil) and by FCT (Portugal) through the 
project PTDC/SAU-ESA/64609/2006.  
References and Notes 
1. Rehm, B.H.A. Bacterial polymers: biosynthesis, modifications and applications. Appl. Ind. 
Microbiol. 2010, 8, 578-592. 
2. Simões, M.; Simões, L.C.; Vieira, M.J. A review of current and emergent biofilm control 
strategies. Food Sci. Technol. 2010, 43, 573-583. 
3. Johnson, J.G.; Clegg, S. Role of MrkJ, a phosphodiesterase, in type 3 fimbrial expression and 
biofilm formation in Klebsiella pneumoniae. J. Bacteriol. 2010, 192, 3944-3950. 
4. Kajiyama, S.; Tsurumoto, T.; Osaki, M.; Yanagihara, K.; Shindo, H. Quantitative analysis of 
Staphylococcus epidermidis biofilm on the surface of biomaterial. J. Orthopaed. Sci. 2009, 14, 
769-767. 
5. Bremer, P.J.; Fillery, S.; McQuillan, A.J. Laboratory scale Clean-In-Place (CIP) studies on the 
effectiveness of different caustic and acid wash steps on the removal of dairy biofilms. 
Int. J. Food Microbiol. 2006, 106, 254-262. 
6. Hammond, A.M.S.; Dertien, J.M.S.; Colmer-Hamood, J.A.; Griswold, J.A.M.D.; Hamood, A.N. 
Serum Inhibits P. aeruginosa Biofilm Formation on Plastic Surfaces and Intravenous. J. Surg. 
Res. 2010, 159, 735-746. 
7. Toney, J.H.; Koh, M.L. Inhibition of Xylella fastidiosa Biofilm Formation via Metal Chelators. J. 
Assoc. Lab. Automat. 2006, 11, 30-32. 
8. Cheng, G.; Zhang, Z.; Chen, S.; Bryers, J.D.; Jiang, S. Inhibition of bacterial adhesion and biofilm 
formation on zwitterionic surfaces. Biomaterials 2007, 28, 4192-4199. 
9. Cateau, E.; Berjeaud, J.M.; Rodiera, M.H.; Christine, I. Fungal biofilm inhibition by a component 
naturally produced by Candida albicans yeasts growing as a biofilm. Int. J. Antimicrob. Agents 
2008, 31,166-170. 




10. Wanga, X.; Yao, X.; Zhua, Z.; Tanga, T.; Daia, K.; Sadovskayac, I.; Flahautc, S.; Jabbouri, S. 
Effect of berberine on Staphylococcus epidermidis biofilm formation. Int. J. Antimicrob. Agents 
2009, 34, 60-66. 
11. Okuda, K.; Hanada, N.; Usui Y.; Takeuchi, H.; Koba, H.; Nakao, R.; Watanabe, H.; Senpuku, H. 
Inhibition of Streptococcus mutans adherence and formation using analogues of the SspB peptide. 
Arch. Oral Biol. 2010, 55, 754-762.  
12. Ndi, C.P.; Semple, S.J.; Griesser, H.J.; Pyke, S.M.; Barton, M.D. Antimicrobial Compounds from 
the Australian Desert Plant Eremophila neglecta. J. Nat. Prod. 2007, 70, 1439-1443. 
13. Horiuchi, K.; Shiota, S.; Hatano, T.; Yoshida, T.; Kuroda, T.; Tsuchiya, T. Antimicrobial activity 
of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant 
enterococci (VRE). Biol. Pharm. Bull. 2007, 30, 1147-1149. 
14. Viano, Y.; Bonhomme, D.; Camps, M.; Briand, J.F.; Ortalo-Magné, A.; Blache, Y.; Piovetti, L.; 
Culioli, G. Diterpenoids from the Mediterranean brown alga Dictyota sp. evaluated as antifouling 
substances against a marine bacterial biofilm. J. Nat. Prod. 2009, 72,1299-1304. 
15. Behal, V. Nontraditional microbial bioactive metabolites. Folia Microbiol. 2001, 46, 363-370. 
16. Salatino, A.; Salatino, M.L.F.; Negri, G. Traditional uses, chemistry and pharmacology of Croton 
species (Euphorbiaceae). J. Braz. Chem. Soc. 2007, 18, 11-33. 
17. Murillo, R.M.; Jakupovic, J.; Rivera, J.; Castro, V.H. Diterpenes and other constituents from 
Croton draco (Euphorbiaceae). Rev. Biol. Trop. 2001, 49, 259-264. 
18. Araujo-Junior, V.T.; da Silva, M.S.; da Cunha, E.V.L.; Agra, M.D.; da Silva, R.N.; Barbosa, J.M.; 
Braz-Filho, R. Alkaloids and Diterpenes From Croton moritibensis. Pharm. Biol. 2004, 42, 62-67. 
19. Peres, M.T.L.P.; Monache, F.D.; Cruz, A.B.; Pizzolatti, M.G.; Yunes, R.A.J. Chemical 
composition and antimicrobial activity of Croton urucurana Baillon (Euphorbiaceae). J. 
Ethnopharmacol. 1997, 56, 223-226. 
20. Maciel, M.A.M.; Pinto, A.C.; Arruda, A.C.; Pamplona, S.G.S.R.; Vanderlinde, F.A.; Lapa, A.J.; 
Echevarria, A.; Grynberg, N.F.; Côlus, I.M.S.; Farias, R.A.F.; Costa, A.M.L.; Rao, V.S.N. 
Ethnopharmacology, phytochemistry and pharmacology: a successful combination in the study of 
Croton cajucara. J. Ethnopharmacol. 2000, 70, 41-55. 
21. Graikou, K.; Aligiannis, N.; Skaltsounis, A.L.; Chinou, I.; Michel, S.; Tillequin, F.; Litaudon, M. 
New diterpenes from Croton insularis. J. Nat. Prod. 2004, 67, 685-688. 
22. Peres, M.T.L.P.; Monache, F.D.; Pizzolatti, M.G.; Santos, A.R.S.; Beirith, A.; Calixto, J.B.; 
Yunes, R.A. Analgesic compounds of Croton urucurana Baillon. Pharmaco-chemical criteria 
used in their isolation. Phytother. Res. 1998, 12, 209-211. 
23. Guadarrama, A.B.A.; Rios, M.Y. Three new sesquiterpenes from Croton arboreus. J. Nat. Prod. 
2004, 67, 914-917. 
24. McChesney, J.D.; Silveira, E.R. Ent-clerodanes of Croton sonderianus. Fitoterapia 1990, 61,  
172-175. 
25. El Mekkawy, S.; Meselhy, M.R.; Nakamura, N.; Hattori, M.; Kawahata, T.; Otake, T. Anti-HIV-1 
phorbol esters from the seeds of Croton tiglium. Phytochemistry 2000, 53, 457-464. 
26. Barbosa, P.R.; Fascio, M.; Martins, D.; Guedes, M.L.S.; Roque, N.F. Triterpenes of Croton 
betulaster (Euphorbiaceae). Biochem. Syst. Ecol. 2003, 31, 307-308. 




27. Giang, P.M.; Son, P.T.; Lee, J.H.; Lee, J.J.; Otsuka, H. Four ent-kaurane diterpenoids from Croton 
tonkinensis Gagnep. Chem. Pharm. Bull. 2004, 52, 879-882. 
28. Santos, H.S.; Barros, F.W.A.; Albuquerque, M.R.J.R.; Bandeira, P.N.; Pessoa, C.; Braz-Filho, R.; 
Monte, F.J.Q.; Leal-Cardoso, J.H.; Lemos, T.L.G. Cytotoxic Diterpenoids from Croton 
argyrophylloides. J. Nat. Prod. 2009, 72, 1884-1887. 
29. Santos, H.S.; Mesquita, F.M.R.; Lemos, T.L.G.; Monte, F.J.Q.; Braz-Filho, R. Diterpenos 
casbanos e acetofenonas de Croton nepetaefolius (Euphorbiaceae).Quím. Nova 2008, 31, 601-604. 
30. Sarikahya, N.B.; Kirmizigül, S. Antimicrobial triterpenoid glycosides from Cephalaria scoparia. 
J. Nat. Prod. 2010, 73, 825-830. 
31. Souza, A.B.; Martins, C.H.; Souza, M.G.; Furtado, N.A.; Heleno, V.C.; de Sousa, J.P.; Rocha, 
E.M.; Bastos, J.K.; Cunha, W.R.; Veneziani, R.C.; Ambrósio, S.R. Antimicrobial activity of 
terpenoids from Copaifera langsdorffii Desf. against cariogenic bacteria. Phytother. Res. 2010, 
DOI: 10.1002/ptr.3244. 
32. Donlan, R.M. Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 2002, 8, 881-890. 
33. Roy, H. Tuning the properties of the bacterial membrane with aminoacylated 
phosphatidylglycerol. IUBMB Life 2009, 61, 940-953.  
34. Priyadarshini, R.; de Pedro, M.A.; Young, K.D. Role of peptidoglycan amidases in the 
development and morphology of the division septum in Escherichia coli. J. Bacteriol. 2007, 189, 
5334-5347.  
35. Coenye, T.; Honraet, K.; Rigole, P.; Nadal, J.P.; Nelis, H.J. In vitro inhibition of Streptococcus 
mutans biofilm formation on hydroxyapatite by subinhibitory concentrations of anthraquinones. 
Antimicrob. Agents Chemother. 2007, 51, 1541-1544. 
36.  Xiang, W.; Song, Q.S.; Zhang, H.J.; Guo, S.P.; Antimicrobial anthraquinones from Morinda 
angustifolia. Fitoterapia 2008, 79, 501-504.  
37. Silipo, A.; Molinaro, A. The diversity of the core oligosaccharide in lipopolysaccharides. Subcell. 
Biochem. 2010, 53, 69-99. 
38. Xu, K.D.; McFeters G.A.; Stewart, P.S. Biofilm resistance to antimicrobial agents. Microbiology 
2000, 3,547-549. 
39. Taweechaisupapong, S.; Singhara, S.; Lertsatitthanakorn, P.; Khunkitti, W. Antimicrobial effects 
of Boesenbergia pandurata and Piper sarmentosum leaf extracts on planktonic cells and biofilm of 
oral pathogens. Pakistan J. Pharm. Sci. 2010, 23, 224-231. 
40. Kuzma, L.; Rózalski, M.; Walencka, E. Rózalska, B.; Wysokinska, H. Antimicrobial activity of 
diterpenoids from hairy roots of Salvia sclarea L.: Salvipisione as a potential anti-biofilm agent 
active against antibiotic resisrant Staphylococci. Phytomedicine 2007, 14, 31-35. 
41. Majtán, J.; Majtánová, L.; Xu, M.; Majtán, V. In vitro effect of subinhibitory concentrations of 
antibiotics on biofilm formation by clinical strains of Salmonella enterica serovar Typhimurium 
isolated in Slovakia. J. Appl. Microbiol. 2007, 104, 1294-1301.  
42. Lau, P.C.; Lindhout, T.; Beveridge, T.J.; Dutcher, J.R.; Lam, J.S. Differential lipopolysaccharide 
core capping leads to quantitative and correlated modifications of mechanical and structural 
properties in Pseudomonas aeruginosa biofilms. J. Bacteriol. 2009, 191, 6618-6631.  
43. Rocchetta, H.L.; Burrows, L.L.; Lam, J.S. Genetics of O-antigen biosynthesis in Pseudomonas 
aeruginosa. Microbiol. Mol. Biol. Rev. 1999, 63, 523-553. 




44. Singh, A.; Prasad, T.; Kapoor, K.; Mandal, A.; Roth, M.; Welti, R.; Prasad, R. Phospholipidome 
of Candida: Each Species of Candida Has Distinctive Phospholipid Molecular Species. OMICS A 
J. Integr. Biol. 2010, 14, 1-14.  
45. Stepanovic, S.; Vukovic, D.; Dakic, I.; Savic, B.; Svabic-Vlahovic, M. A modified microtiter-
plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 2000, 40, 
175-179. 
46. Burton, E.; Yakandawala, N.; LoVetri, K.; Madhyastha, M.S. A microplate spectrofluorometric 
assay for bacterial biofilms. J. Ind. Microbiol. Biotechnol. 2007, 34, 1-4.  
Sample Availability: Contact the authors. 
© 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/) 
